The AHA Guidelines and Scientific Statements Handbook

355

Index

A-actin 238
A-actinin-2 240
A-cardiac actin 240
A-myosin 238, 240
A-tropomyosin 238, 240
Abciximab 35, 37, 57, 64, 130
ABI 166–8, 170–1, 174, 176, 182–3
Ablation 246, 253–4, 256, 260–9, 275, 285, 289
asymptomatic PVC 275
catheter 74, 281
purkinje fi ber potential 275
RF 262
Abscess 282, 309–10, 313–7, 325, 330
ABSOLUTE trial 186
ACCORD 116
Accuracy, diagnostic 340, 343
ACE 33–4, 43, 64, 67–8, 70, 87, 168, 174–6, 218, 235
inhibitor, see ACEI
ACEI 109–11, 114–5, 139, 175, 204, 206–13, 220, 227–34
Acetaminophen 78, 85
ACS 28, 31–3, 37, 39, 45, 145, 159, 188, 271
ACTION 103
Acute Catheterization and Urgent Intervention Triage
Strategy 30, 31, 45
Acute coronary syndromes. See ACS
Acute respiratory distress syndrome 142
Adenoma 212
Adenosine 75, 82–3, 256–60, 263–4, 266, 268–9
Adriamycin 241
Adult Treatment Panel III. See ATP III
Advanced cardiac life support 50–1
Advanced Cardiac Life Support Subcommittee 271
AF 66, 68, 74, 80, 137, 140, 142, 158, 163, 229, 231–2,
234, 244–54, 255, 257–9, 263–9, 275, 285, 302–7,
311, 343
Copenhagen 247–8
lone 246, 249, 253
nonvalvular 247–8
paroxysmal 246, 253
persistent 245, 251–2

pharmacological cardioversion 249–50

rate control, pharmacological 244

recurrent 251, 253

AFASAK 247–8

Agonists, alpha-2 152, 161–2

Ajmaline 276, 290

Albuminuria 202, 210

Aldosterone antagonist 208–9, 212, 230, 233–5

Aldosterone blocker 227

Aldosterone, system 64, 68

Aldosteronism 202

Amaurosis 53

Ambulatory blood pressure 201

American Academy of Pediatrics 332

American Dental Association 332

American Diabetes Association 210

Aminophylline 259

Amiodarone 72–4, 232, 245–6, 249–50, 265–9, 276–81,

284–6, 290

Amiodarone Trial Meta Analysis 281

Amiodarone versus Inplantable Cardioverter-Defi brillator

276–81, 284–6, 290

Amoxicillin 333

Amyloidosis 241

Analgesia/anxiolytics 67

Anatomy, coronary 149

Andersen syndrome 239

Anesthesia 72–5, 162

Aneurysm 186, 344–5

abdominal aortic 205, 215, 217, 219–20

mycotic 314

ventricular 71

Angina 4, 5, 14, 17, 29, 31, 32, 37, 41, 53, 61, 66–7, 72–3,

80–2, 134, 136–7, 139, 144–51, 155, 160, 162, 168,

178, 188, 202, 208–9, 225, 232, 250

atypical 5

chronic stable. See CSA

stable 8, 13, 22

unstable. See UA

vasospastic 19

The AHA Guidelines and Scientific Statements Handbook
Edited by Valentin Fuster © 2009 American Heart Association
ISBN: 978-1-405-18463-2